> That's not what this article says, and it's not true. Obesity isn't a risk factor for addiction, and is only a very weak risk factor for things like Parkinson's. Most of the people in these studies are probably diabetics taking it for diabetes and may not have even been obese to begin with.
Prevent the body (and mind) from functioning naturally (in an historic / evolutionary sense) and bad tbings happen. Obesity is the cherry on top of the cake of unhealthy diet and lifestyle.
The question is: what happens to Ozempic users over the long term? If you start on it at 18 y/o (or whatever the approved age is) what happens in 5 yrs, 10 yrs, etc. Statins eventually hit the wall so to speak, will these other system-altering drugs do the same?
> There are two plausible places GLP-1 drugs could lower weight: the body or the brain. In the body, it could change stomach contraction rate, hormone production, etc. In the brain, it could control the mental sensation of hunger. To separate these two effects, scientists bred rats that only had GLP-1 receptors in the body vs. in the brain. The results were unequivocal: Ozempic and its relatives work in the brain. Although they have some effects in the body, these are short-lived and not really relevant to their mechanism of action for weight loss.
This should've been obvious the moment there was evidence GLP-1 agonists were preventing addictive behaviors, versus solely digestive system effects. Interestingly, this works by crossing the blood brain barrier, so the next question is: can you speed up the effects by temporarily opening that barrier using ultrasound such is done for Alzheimer's treatment [1]?